UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

Explore how large language models enhance knowledge graphs in drug discovery and improve data management and reasoning.

Portland-based biotech company Araceli Biosciences raised $11.2 million in new funding to fuel the expansion of its ...

Three Gallaudet Biology students won honors and cash prizes in this year's NASA DC Space Grant Consortium’s student poster ...

Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...

A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery.

Additionally, it provides hands-on training for the next generation of scientists through seminars, internship programs, and AI-driven drug discovery hackathons. The new Center builds on other ...

Plan now to have your poster included in the 2026 Drug Discovery & Development Virtual Event. Submission is free. Submit your abstract here. Our virtual conference allows you to participate in a ...

A new company has entered the drug discovery space with what it calls a “chemistry-first” platform. Colorado-based Cime Therapeutics has emerged from stealth with $2.1 million in preseed financing to ...

Drug Discovery Chemistry is a heavyweight industry event. It draws thousands of scientists, biotech innovators, and pharmaceutical executives from around the world each year. The topics set for the ...

A natural protein could revolutionize cancer treatments by facilitating drug absorption into cells. Researchers have ...

Are we in denial about the state of drug discovery? This is a question I recently asked a room full of leading thinkers from the pharmaceutical, academic, and nonprofit worlds assembled for a Wellcome ...